Physician

Brett J Eliuk, D.O.

According to 2025 Medicare claims, Brett Eliuk, D.O. (NPI: 1871714915) practices cardiology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is KOOTENAI HEALTH, INC. (NPI: 1174661151; TIN: 820380784) and primary practice location at 83814-2656. Eliuk is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Eliuk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,731 traditional Medicare patients, billed 4,829 HCPCS/CPT codes, and received $192,655 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,378 prescription claims across 683 beneficiaries totaling $1,485,041 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 183 claims. Open Payments data shows 9 records totaling $787. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $347,832 to $1,485,041. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $18,102 to $5,137.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,384	5,020	$245,178
2016	2,267	5,012	$231,229
2017	2,302	4,623	$214,229
2018	2,115	4,230	$195,444
2019	2,227	4,339	$207,885
2020	1,819	3,554	$175,129
2021	1,891	3,944	$187,877
2022	1,817	3,742	$164,528
2023	1,720	4,523	$191,175
2024	1,731	4,829	$192,655

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	539	4,426	$347,832
2016	611	5,131	$492,381
2017	659	5,830	$664,072
2018	721	5,901	$828,397
2019	747	5,351	$913,389
2020	823	5,760	$1,148,849
2021	911	6,312	$1,385,659
2022	873	3,818	$952,158
2023	579	2,523	$606,636
2024	683	4,378	$1,485,041

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	164	$16,053
2018	N/R	196	$7,024
2019	N/R	235	$6,682
2020	N/R	211	$6,745
2021	N/R	183	$7,110
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	208	227	$77
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	715	723	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	305	345	$12
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	207	210	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	644	722	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	392	26,310	$500,273
Vyndamax	Tafamidis	13	390	$296,122
Entresto	Sacubitril/Valsartan	118	9,270	$197,231
Jardiance	Empagliflozin	81	6,630	$124,535
Xarelto	Rivaroxaban	78	3,960	$71,173

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$787	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brett J. Eliuk, D.O.?

Tedicare shows public-source Medicare data for Brett J. Eliuk, D.O. (NPI 1871714915), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brett J. Eliuk, D.O. have ACO affiliation data?

Brett J. Eliuk, D.O. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Brett J. Eliuk, D.O.?

Brett J. Eliuk, D.O. is linked to KOOTENAI HEALTH, INC. (billing NPI 1174661151) in the available physician profile data.

Does Brett J. Eliuk, D.O. have Open Payments data?

Brett J. Eliuk, D.O. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.